These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Acute Rejection Rates and Graft Outcomes According to Induction Regimen among Recipients of Kidneys from Deceased Donors Treated with Tacrolimus and Mycophenolate. Tanriover B; Jaikaransingh V; MacConmara MP; Parekh JR; Levea SL; Ariyamuthu VK; Zhang S; Gao A; Ayvaci MUS; Sandikci B; Rajora N; Ahmed V; Lu CY; Mohan S; Vazquez MA Clin J Am Soc Nephrol; 2016 Sep; 11(9):1650-1661. PubMed ID: 27364616 [TBL] [Abstract][Full Text] [Related]
32. Post-transplant lymphoproliferative disorder in adult liver transplant recipients: a South American multicenter experience. Mendizabal M; Marciano S; dos Santos Schraiber L; Zapata R; Quiros R; Zanotelli ML; Rivas MM; Kusminsky G; Humeres R; Alves de Mattos A; Gadano A; Silva MO Clin Transplant; 2013; 27(4):E469-77. PubMed ID: 23758407 [TBL] [Abstract][Full Text] [Related]
33. Lymphocyte depletion and risk of acute rejection in renal transplant recipients at increased risk for delayed graft function. Ravindra KV; Sanoff S; Vikraman D; Zaaroura A; Nanavati A; Sudan D; Irish W Am J Transplant; 2019 Mar; 19(3):781-789. PubMed ID: 30171800 [TBL] [Abstract][Full Text] [Related]
34. Transplantation in foreign nationals: Lower rates of waitlist mortality and higher rates of lost to follow-up posttransplant. Ferrante ND; Goldberg DS Am J Transplant; 2018 Nov; 18(11):2663-2669. PubMed ID: 29981179 [TBL] [Abstract][Full Text] [Related]
35. Functional status at listing predicts waitlist and posttransplant mortality in pediatric liver transplant candidates. Perito ER; Bucuvalas J; Lai JC Am J Transplant; 2019 May; 19(5):1388-1396. PubMed ID: 30506640 [TBL] [Abstract][Full Text] [Related]
36. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients. Hill P; Cross NB; Barnett AN; Palmer SC; Webster AC Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004759. PubMed ID: 28073178 [TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of tacrolimus in de novo pediatric transplant recipients randomized to receive immediate- or prolonged-release tacrolimus. Vondrak K; Parisi F; Dhawan A; Grenda R; Webb NJA; Marks SD; Debray D; Holt RCL; Lachaux A; Kelly D; Kazeem G; Undre N Clin Transplant; 2019 Oct; 33(10):e13698. PubMed ID: 31436896 [TBL] [Abstract][Full Text] [Related]
38. Beyond death and graft survival-Variation in outcomes after liver transplant. Results from the NSQIP transplant beta phase. Parekh JR; Greenstein S; Sudan DL; Grieco A; Cohen ME; Hall BL; Ko CY; Hirose R Am J Transplant; 2019 Jul; 19(7):2108-2115. PubMed ID: 30887634 [TBL] [Abstract][Full Text] [Related]
39. Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients. Kuo HT; Huang E; Emami S; Pham PT; Wilkinson AH; Danovitch GM; Bunnapradist S Transplantation; 2012 Mar; 93(5):493-502. PubMed ID: 22306574 [TBL] [Abstract][Full Text] [Related]
40. Kidney allograft function and histology in recipients dying with a functioning graft. Lorenz EC; El-Zoghby ZM; Amer H; Dean PG; Hathcock MA; Kremers WK; Stegall MD; Cosio FG Am J Transplant; 2014 Jul; 14(7):1612-8. PubMed ID: 24910299 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]